Literature DB >> 11600839

Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil.

C Brites1, R Alencar, R Gusmão, C Pedroso, E M Netto, D Pedral-Sampaio, R Badaró.   

Abstract

Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To evaluate its impact on survival, we conducted a retrospective, case-control study involving 198 patients (63 cases). Co-infection was associated with parenteral exposure (P = 0.0001) and female sex (P = 0.02). Co-infected patients had a shorter mean survival (1849 days) than controls (2430 days, P = 0.001), regardless of sex or baseline CD4 cell count. In Bahia, Brazil, co-infection with HIV-1 and HTLV-1 is associated with a shorter survival time.

Entities:  

Mesh:

Year:  2001        PMID: 11600839     DOI: 10.1097/00002030-200110190-00023

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

1.  Alterations in T cell subsets in human immunodeficiency virus-infected adults with co-infections in southern Mozambique.

Authors:  Denise Naniche; Emilio Letang; Tacilta Nhampossa; Catarina David; Clara Menendez; Pedro Alonso
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.

Authors:  Adele Caterino-de-Araujo; Cláudio Tavares Sacchi; Maria Gisele Gonçalves; Karoline Rodrigues Campos; Mariana Cavalheiro Magri; Wong Kuen Alencar
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-02       Impact factor: 2.205

Review 3.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

4.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

5.  Predictive factors of HTLV1-HIV coinfections in French Guiana.

Authors:  Elise Gouhier; Emilie Gaubert-Maréchal; Philippe Abboud; Pierre Couppié; Mathieu Nacher
Journal:  Am J Trop Med Hyg       Date:  2013-08-12       Impact factor: 2.345

Review 6.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

Review 7.  Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review.

Authors:  Carolina Alvarez; Eduardo Gotuzzo; Anne-Mieke Vandamme; Kristien Verdonck
Journal:  Front Microbiol       Date:  2016-10-28       Impact factor: 5.640

8.  Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.

Authors:  Adele Caterino-de-Araujo; Fabiana Aparecida Alves; Karoline Rodrigues Campos; Marcílio Figueiredo Lemos; Regina Célia Moreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02       Impact factor: 2.743

9.  Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2.

Authors:  Glorilee Balistrieri; Christy Barrios; Laura Castillo; Tochi C Umunakwe; Chou-Zen Giam; Huijun Zhi; Mark A Beilke
Journal:  Viral Immunol       Date:  2013-01-03       Impact factor: 2.257

10.  HTLV-1 and HIV-1 co-infection: A case report and review of the literature.

Authors:  Carmen Isache; Michael Sands; Nilmarie Guzman; Danisha Figueroa
Journal:  IDCases       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.